M MELTECH
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Jan 2025)
What this means for you
Registered since 12 Feb 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87646531
- Registration number
- 5672365
- Mark type
- Word mark
- Filed
- 16 Oct 2017
- Published for opposition
- 27 Nov 2018
- Registered
- 12 Feb 2019
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, oncological, ] fungal and viral diseases and disorders
Owner
- Dexcel Pharma Technologies Ltd., Jerusalem, IL
- Dexcel Pharma Technologies Ltd., 3060000 Or Akiva, IL
- Dexcel Pharma Technologies Ltd., 3060000 Or Akiva, IL
Prior registrations
Prosecution history
- 31 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 12 Feb 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Feb 2019 — REGISTERED-PRINCIPAL REGISTER
- 27 Nov 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Nov 2018 — PUBLISHED FOR OPPOSITION
- 07 Nov 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Oct 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Oct 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Oct 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Oct 2018 — ASSIGNED TO LIE
- 05 Oct 2018 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 13 Apr 2018 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED